What Is Deep Brain Stimulation? The procedure involves implanting electrodes within areas of the brain for people with movement conditions. "The electrodes produce electrical impulses that affect ...

Medicare covers deep brain stimulation (DBS) for eligible people diagnosed with essential tremors or idiopathic Parkinson’s disease to help reduce tremors and improve daily activities. To qualify for ...

There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain stimulator that could benefit patients with the motor condition. On Feb 24, ...

Deep brain stimulation can significantly reduce depressive symptoms in some individuals. Knowing what to expect before and after the procedure may help you determine if it’s right for you. Deep brain ...

In a new frontier for deep brain stimulation, researchers used A.I. to develop individualized algorithms, which helped a skateboarder and other patients with Parkinson’s disease. By Pam Belluck ...

Electricity is the brain’s language. For a decade, National Institutes of Health (NIH) funding and philanthropy have enabled UC San Francisco physician-scientists to decipher this language and use ...

Deep brain stimulation is a surgical brain therapy used to treat symptoms of movement disorders such as dystonia, Parkinson’s disease and epilepsy. Performing over 100 DBS procedures annually, the ...

An early-stage clinical trial has shown that deep brain stimulation (DBS) applied to the cerebellum may aid the recovery of upper limb function after stroke. Researchers studied 12 people with ...

A new study led by Bucknell University Professor Karlo Malaga, biomedical engineering, has identified key insights into optimizing deep brain stimulation (DBS) for Parkinson's disease patients.

While stuttering was believed to have purely psychological causes up until about 30 years ago, scientists today attribute it to a variety of factors capable of contributing to its development. For ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach to ...